PENVARD

This brand name is authorized in Nigeria.

Active ingredients

The drug PENVARD contains one active pharmaceutical ingredient (API):

1	Phenoxymethylpenicillin UNII 146T0TU1JB - PENICILLIN V POTASSIUM
	Phenoxymethylpenicillin is a broad spectrum beta-lactam antibiotic. Phenoxymethylpenicillin binds to penicillin-binding proteins located on the inner membrane of the bacterial cell wall. Phenoxymethylpenicillin binds to and inactivates these proteins resulting in weakening of the bacterial cell wall and lysis.
	Read more about Phenoxymethylpenicillin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3187	Tablet	Penvard Tablets (strength format) TAB 312.5mg 1 x 10's (in plastic container)	Tablet White circular uncoated tablets having "PENICILLIN V" embossed on one side and "500000 IU" with break line on other side of each tablet. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. PENVARD TABLETS B4-3187 PENVARD TABLETS Each uncoated tablet contains: Penicillin V Potassium USP eq. to Penicillin V 5, 00,000IU (EQ 312.5mg) Excipients with known effects: Each tablet contains 50.00 mg of Lactose, 6.50 mg of Magnesium Stearate. List of excipients Lactose, Maize Starch, PVPK-30, Purified Talc, Colloidal Silicon Dioxide, Sodium Starch Glycollate, Magnesium Stearate. Prescription Only Medicine (POM) DE - GODSTIME INDUSTRY NIG LTD, 9 Belonwu Street, fegge onitsha. VARDHMAN EXPORTS, A-188, T.T.C. M.I.D.C INDL. AREA, KHAIRNE, NAVI MUMBAI-400710. MAHARASHTRA STATE, INDIA, India 2/23/2023 2/22/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CE02	Phenoxymethylpenicillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CE Beta-lactamase sensitive penicillins
Discover more medicines within J01CE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3187